BPSR insider trading

Organicell Regenerative Medicine, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
289
Last 90 days
0
Buys / sells
4% / 71%
Market cap
—

BPSR insider activity at a glance

FilingIQ tracks 289 insider transactions for BPSR in filings since Jun 26, 2015. The most recent transaction is dated Oct 29, 2021.

Across the full history, 13 open-market purchases and 204 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BPSR insider trades is 53.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest BPSR Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for BPSR?
FilingIQ tracks 289 Form 4 insider transactions for BPSR (Organicell Regenerative Medicine, Inc.), covering filings from Jun 26, 2015 onwards. 0 of those are dated within the last 90 days.
Are BPSR insiders net buyers or net sellers?
Across the full Form 4 history for BPSR, 13 transactions (4%) were open-market purchases and 204 (71%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BPSR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every BPSR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.